Impaired Expression of Membrane Type-2 and Type-3 Matrix Metalloproteinases in Endometriosis but Not in Adenomyosis
article
OA: gold
CC0
⤵ 2 in-corpus citations
AI-generated summary
This study found decreased expression of MT2-MMP and MT3-MMP in ectopic endometrial tissue from endometriosis patients compared to eutopic endometrium and adenomyosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Matrix metalloproteinases (MMPs) play an important role in menstruation and endometriosis; however, the membrane-type matrix metalloproteinases (MT-MMPs) are not well studied in endometriosis and adenomyosis. We analyzed MT2-MMP (MMP15) and MT3-MMP (MMP16) in eutopic endometrium with and without endometriosis and with and without adenomyosis and ectopic endometrium of deep infiltrating endometriosis (DIE), peritoneal endometriosis (PE), and ovarian endometriosis (Ov) by immunohistochemistry. Preferential expression of both proteins was observed in the glandular and luminal epithelial cells of the eutopic endometrium of patients with and without endometriosis with a ~2.5-fold stronger expression of MT3-MMP compared to MT2-MMP. We did not observe any differences during menstrual cycling and in eutopic endometrium of patients with and without endometriosis. Similarly, eutopic endometrium and adenomyotic tissue with and without endometriosis showed similar protein levels of MT2-MMP and MT3-MMP. In contrast, MT2-MMP and MT3-MMP protein was decreased in ectopic compared to eutopic endometrium and adenomyosis. The similar expression of MT2-MMP and MT3-MMP in eutopic endometrium in patients with and without endometriosis in contrast to the impaired expression in ectopic endometrium suggests that alterations occur after and not before endometrial implantation possibly by distinct interactions with the different environments. The differential protein expression of MT2/3-MMP in adenomyosis compared to endometriosis might suggest a different pathogenesis pathway for the two diseases.
My notes (saved in your browser only)
Condition tags
Funding
- funders
- [{'doi': '10.13039/501100001655', 'name': 'German Academic Exchange Service', 'awards': ['91731459 and 91560545']}]
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (97)
- Adenomyosis. via openalex
- Adenomyosis: Back to the future? via openalex
- Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease via openalex
- Adenomyotic glands are highly related to endometrial glands via openalex
- Comparison of revised American Fertility Society and ENZIAN staging: a critical evaluation of classifications of endometriosis on the basis of our patient population via openalex
- Diagnostic findings in adenomyosis: a pictorial review on the major concerns. via openalex
- Endometriosis: Epidemiology, Diagnosis and Clinical Management via openalex
- Endometriosis: its association with retrograde menstruation, dysmenorrhoea and tubal pathology via openalex
- Endometriosis: its association with retrograde menstruation, dysmenorrhoea and tubal pathology via crossref
- Epithelial–Mesenchymal Transition in Endometriosis—When Does It Happen? via crossref
- Epithelial–Mesenchymal Transition in Endometriosis—When Does It Happen? via openalex
- Expression of Cyclooxygenase-2 and Matrix Metalloproteinase-2 in Adenomyosis and Endometrial Polyps and its Correlation With Angiogenesis via openalex
- Expression of membrane-type 5 matrix metalloproteinase in human endometrium and endometriosis via openalex
- Incidence and Estimated Prevalence of Endometriosis and Adenomyosis in Northeast Italy: A Data Linkage Study via openalex
- Is Endometriosis More Common and More Severe Than It Was 30 Years Ago? via openalex
- Localization of Matrix Metalloproteinase-2 in Uterine Endometrium and Ectopic Implants via openalex
- Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium via openalex
- Pathogenesis and pathophysiology of endometriosis via openalex
- Pathogenesis of uterine adenomyosis: invagination or metaplasia? via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via crossref
- Retrograde menstruation in healthy women and in patients with endometriosis. via openalex
- Superficial peritoneal endometriotic lesions are histologically diverse and rarely demonstrate menstrual cycle synchronicity with matched eutopic endometrium via openalex
- Superficial peritoneal endometriotic lesions are histologically diverse and rarely demonstrate menstrual cycle synchronicity with matched eutopic endometrium via crossref
- Survivin, MMP-2, MT1-MMP, and TIMP-2: their impact on survival, implantation, and proliferation of endometriotic tissues via openalex
- The bimodal role of matrix metalloproteinases and their inhibitors in etiology and pathogenesis of endometriosis (Review) via openalex
- The Pathogenesis of Adenomyosis vis-à-vis Endometriosis via crossref
- The Pathogenesis of Adenomyosis vis-à-vis Endometriosis via openalex
- The role of the peritoneum in the pathogenesis of endometriosis via openalex
- Three-dimensional architectures of peritoneal endometriosis via openalex
- Three-dimensional understanding of the morphological complexity of the human uterine endometrium via openalex
- Uterine cavity matrix metalloproteinases and cytokines in patients with leiomyoma, adenomyosis or endometrial polyp via openalex
- doi:10.1387/ijdb.160286ds via crossref
- doi:10.1158/0008-5472.can-14-1923 via crossref
- doi:10.1016/s0002-9440(10)65288-1 via crossref
- doi:10.1016/j.isci.2021.102258 via crossref
- W1922516116 via openalex
- W1964677239 via openalex
- W1975288990 via openalex
- W1978941213 via openalex
- W1995164247 via openalex
- W2019601632 via openalex
- W2022386452 via openalex
- W2081165140 via openalex
- W2089988721 via openalex
- doi:10.1016/s0140-6736(04)17403-5 via crossref
- W2111275713 via openalex
- W2126537525 via openalex
- W2129394604 via openalex
- W2195567380 via openalex
- W2418297024 via openalex
- W2460446662 via openalex
- W2739143810 via openalex
- W2763254895 via openalex
- W2765750028 via openalex
- W3026935851 via openalex
- W3165294846 via openalex
- W4211081176 via openalex
- W6628680024 via openalex
- W6686679000 via openalex
- W6687537543 via openalex
- W6717469373 via openalex
- W6770092756 via openalex
- W6777374595 via openalex
- W6846383877 via openalex
- W2102407084 via openalex
- doi:10.1097/pap.0b013e3180ca7d7b via crossref
- doi:10.1016/s0015-0282(16)55012-2 via crossref
- doi:10.1016/j.cell.2021.04.041 via crossref
- doi:10.1016/j.jmig.2019.11.018 via crossref
- doi:10.1093/humupd/dmt024 via crossref
- doi:10.1007/s13669-017-0187-1 via crossref
- doi:10.1186/s12958-016-0185-6 via crossref
- doi:10.1371/journal.pone.0154227 via crossref
- doi:10.1016/j.fertnstert.2017.12.030 via crossref
- doi:10.1016/j.rbmo.2019.11.007 via crossref
- doi:10.1016/j.bbapap.2011.09.003 via crossref
- doi:10.1002/cncr.10355 via crossref
- doi:10.1016/j.fertnstert.2012.06.029 via crossref
- doi:10.1016/j.matbio.2015.03.004 via crossref
- doi:10.1016/s0015-0282(02)03322-8 via crossref
- doi:10.1007/s00428-012-1301-4 via crossref
- doi:10.1093/molehr/gah257 via crossref
- doi:10.1095/biolreprod.103.015933 via crossref
- doi:10.1095/biolreprod62.1.85 via crossref
- doi:10.1080/09513590701556921 via crossref
- doi:10.1016/j.fertnstert.2011.01.135 via crossref
- doi:10.1016/j.fertnstert.2017.08.036 via crossref
- doi:10.1177/1933719117734319 via crossref
- doi:10.1016/s0301-2115(03)00244-6 via crossref
- doi:10.1097/pgp.0b013e318187033b via crossref
- doi:10.1159/000009978 via crossref
- doi:10.1016/j.bbrc.2010.01.105 via crossref
- doi:10.18632/oncotarget.10194 via crossref
- doi:10.1242/jcs.115.17.3427 via crossref
- doi:10.1053/plac.1999.0447 via crossref
- doi:10.1093/brain/awg285 via crossref
Cited by (2)
Source provenance
- crossref
- last seen: 2026-05-10T19:04:14.899882+00:00
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-06-04T00:34:54.200900+00:00
License: CC0
· commercial use OK